Peptide therapy TikTok advice: what the science actually supports

What did @realalejandroreyes actually say?

The creator is talking about tesamorelin, a synthetic growth hormone-releasing hormone (GHRH) analog. The transcript is garbled in places, but the core claims are identifiable: tesamorelin improves recovery and sleep, burns "stubborn belly fat," decreases lipogenesis (fat cell creation), increases lipolysis (fat breakdown), and should be taken at night to align with the body's natural growth hormone pulse. These are real claims that deserve real scrutiny, not just a shrug.

To be fair, the creator is pointing toward mechanisms that actually exist in the literature. That's more than most peptide TikToks manage. But vague delivery and missing context can mislead people who are making actual health decisions based on a 60-second video.

Does the science back this up?

Partially, yes, and that's not nothing. Tesamorelin has one of the stronger evidence bases of any peptide in this category, which sets it apart from, say, BPC-157 or TB-500.

The FDA approved tesamorelin (brand name Egrifta) specifically for reducing visceral adipose tissue (VAT) in HIV-associated lipodystrophy. That approval is based on randomized controlled trials, including Stanley et al. (2012, NEJM) showing statistically significant reductions in visceral fat versus placebo. The mechanism the creator gestures at, increased lipolysis and reduced lipogenesis via elevated IGF-1 and growth hormone, is real and documented.

On sleep: growth hormone secretion is strongly tied to slow-wave sleep. A GHRH analog can amplify the nocturnal GH pulse, which is why nighttime dosing makes physiological sense. Van Cauter et al. (2000, Sleep) established this relationship clearly. The creator gets credit for the timing rationale, even if the explanation was muddled.

What did they get wrong (or right)?

The creator got the core mechanisms directionally correct but oversimplified in ways that matter.

• Lipolysis and lipogenesis: Accurate that tesamorelin shifts the balance toward fat breakdown. But this effect is most documented for visceral fat specifically, not subcutaneous "belly fat" in general. Calling it "stubborn belly fat" glosses over that distinction in a way that sets up unrealistic expectations.
• Sleep and recovery: The claim that "you're going to knock out" is anecdotal and unsupported by controlled data. Tesamorelin may enhance GH-related sleep quality effects, but it is not a sedative and the evidence for subjective sleep improvement in healthy adults is thin.
• "Producing more both more": This is incoherent in the transcript, likely referring to IGF-1 or GH production. The idea is plausible but the delivery is not informative enough to evaluate fairly.
• What they missed: No mention of the fact that tesamorelin is a prescription compound. No mention of side effects including fluid retention, joint pain, glucose dysregulation, and potential IGF-1-related risks with long-term use. That's a significant omission for a public-facing health video.

What should you actually know?

Tesamorelin is not a general-purpose fat loss peptide. Its FDA approval is narrow and specific. Using it outside that indication is off-label, and the long-term safety data in metabolically healthy adults is limited.

The nocturnal dosing logic is sound and grounded in endocrinology. If you are working with a physician who has prescribed tesamorelin, timing it with your natural GH pulse is reasonable. But "taking it to bed" is not a hack you pick up from TikTok.

Anyone considering tesamorelin should know: it can raise fasting glucose levels. Falutz et al. (2010, Lancet HIV) found meaningful increases in HbA1c in some participants. If you have prediabetes or insulin resistance, this is not a minor footnote. A prescribing provider needs to assess your metabolic baseline before this compound is appropriate.

Compounded tesamorelin, which is what most people outside HIV care are actually accessing, is not the same as FDA-approved Egrifta. Purity, potency, and sterility vary by compounding pharmacy. That difference is not academic.

Bottom line

This video is more grounded than the average peptide TikTok. The mechanism claims around lipolysis and nighttime GH pulses have real science behind them. But missing context about prescription status, side effects, glucose risk, and the specific population studied makes this a starting point at best, not medical guidance. The creator's confidence exceeds what the evidence supports for general use.